
CBI launches probe into Puducherry counterfeit drugs case
The Hindu
CBI investigates Puducherry counterfeit drugs case, uncovering illegal manufacturing and distribution affecting public health and national security.
The Central Bureau of Investigation (CBI) has registered two cases against suspects involved in the sensational counterfeit drugs sale case in Puducherry.
Acting on a request made by the Government of Puducherry, the CBI’s Anti Corruption Unit, Delhi, registered the cases against three suspects on charges of illegal drug manufacturing, storage, distribution and related offences detected at Mettupalayam and Sedarapet areas of the union territory of Puducherry.
In simultaneous searches conducted on suspected premises between September 1 and December 12, 2025, the Department of Drugs Control, Puducherry, found several drug manufacturing units were functioning in violation of the provisions under the Drugs and Cosmetics Act, 1940, which relate to manufacture, storage and sale of pharmaceutical products.
To prevent the continuation of the illegal activities, the premises were sealed and large quantities of finished pharmaceutical products, raw materials, machinery and equipment were seized.
Samples drawn from the seizures were sent to the Central Drugs Testing Laboratory, Chennai, for a detailed analysis regarding quality, safety and statutory compliance.
A case was registered by the local police which was later transferred to the Crime Branch Criminal Investigation Department for further investigation.













